Molecular Cytogenetics Market is Expected to Reach USD 5.2 Billion by 2031: Says AMR

Rise in number of genetic disorders such as tumors and cancer propels the growth of the global molecular cytogenetics market. By end-user, the clinical and research laboratories segment garnered the major share in 2021. By region, on the other hand, Asia-Pacific would portray the fastest CAGR by 2031.


Portland, OR, Nov. 04, 2022 (GLOBE NEWSWIRE) -- According to the report published by Allied Market Research, the global Molecular Cytogenetics Market size was estimated at $2.2 billion in 2021 and is expected to hit USD 5.2 billion by 2031, registering a CAGR of 8.7% from 2022 to 2031. The report provides a detailed analysis of the top investment pockets, top winning strategies, drivers & opportunities, market size & estimations, competitive landscape, and evolving market trends. The market study is a helpful source of information for the frontrunners, new entrants, investors, and shareholders in crafting strategies for the future and heightening their position in the market. The report is exclusively meant to help the readers with a comprehensive valuation of industry analysis and trends.

Download Free Sample Report (310 Pages PDF with Insights, Charts, Tables, Figures): https://www.alliedmarketresearch.com/request-sample/12663

Report coverage & details:

Report CoverageDetails
Forecast Period2022­–2031
Market Size in 2031$5.2 Billion
CAGR8.7%
No. of Pages in Report310
Segments CoveredProduct, Technique, Application, End-user, and Region.
Drivers Rise in number of genetic disorders such as tumors and cancer
OpportunitiesIncrease in funding for research and clinical diagnosis
RestraintsHigh cost of treatment and lack of awareness about the emerging diagnostic technologies in molecular cytogenetics


Covid-19 scenario-

  • There were several reports of the majority of hospitals operating at less than fifty percent capacity to curtail non-essential medical services.
  • Hospitals were even less likely to conduct molecular cytogenetics tests, which impacted the global molecular cytogenetics market negatively. However, the market has now got back on track.

The global molecular cytogenetics market is analyzed across product, technique, application, end user, and region. The report takes in an exhaustive analysis of segments and their sub-segments with the help of tabular and graphical representation. Investors and market players can benefit from the breakdown and devise stratagems based on the highest revenue-generating and fastest-growing segments stated in the report.

Based on product, the consumables segment contributed to nearly two-thirds of the global molecular cytogenetics market revenue in 2021, and is expected to dominate by 2031. The software and services segment, on the other hand, would showcase the fastest CAGR of 9.9% throughout the forecast period.

Purchase Inquiry:
https://www.alliedmarketresearch.com/purchase-enquiry/12663

Based on technique, the comparative genomic hybridization segment accounted for nearly half of the total market revenue in 2021, and is expected to dominate by 2031. The same segment would also cite the fastest CAGR of 9.3% throughout the forecast period.

Based on application, the genetic disorders segment held nearly two-fifths of the total market revenue in 2021, and is expected to dominate by 2031. The personalized medicines segment, simultaneously, would portray the fastest CAGR of 10.1% throughout the forecast period.

By end-user, the clinical and research laboratories segment garnered around half of the total market revenue in 2021, and is anticipated to lead the trail by 2031. the same segment would also display the fastest CAGR of 9.4% from 2022 to 2031.

Based on region, the market across North America generated more than two-fifths of the total market revenue in 2021, and is anticipated to retain the lion’s share by 2031. The Asia-Pacific region would also showcase the fastest CAGR of 10.9% during the forecast period. The other regions studied in the report include Europe and LAMEA.

The key market players analyzed in the global molecular cytogenetics market report include Genial Genetic Solutions Ltd., Agilent Technologies Inc., Applied Spectral Imaging, Danaher Corporation (Cephied), Illumina, Inc., Perkinelmer, Inc., Cyto Test Inc., Abbott Laboratories, Sema4 Holdings Corp., Sysmex Corporation (Oxford Gene Technology), Thermo Fisher Scientific Inc., and Empire Genomics, LLC.  These market players have embraced several strategies including partnership, expansion, collaboration, joint ventures, and others to highlight their prowess in the industry. The report is helpful in formulating the business performance, product portfolio, operating segments, and developments by the top players. 


Trending Reports in Healthcare Industry (Book Now with 10% Discount):

IVF Services Market by Cycle Type (Fresh IVF Cycles (Non-donor), Thawed IVF Cycles (Non-donor), and Donor Egg IVF Cycles) and End User (Fertility Clinics, Hospitals, Surgical Centers, and Clinical Research Institutes): Global Opportunity Analysis and Industry Forecast, 2020-2030

Vaccines Market by Technology Type (Recombinant & Conjugate Vaccines, Live Attenuated Vaccines, Inactivated Vaccines, Toxoid Vaccines, and Other Vaccines), Indication (Pneumococcal Disease, Influenza, Human Papilloma Virus, Meningococcal Disease, Rotavirus, Varicella, Measles, Mumps, & Rubella {MMR}, Diphtheria, Pertussis, & Tetanus {DPT}, Polio, Hepatitis, and Other Indications), and End User (Pediatric, Adults, and Travelers): Global Opportunity Analysis and Industry Forecast, 2021-2031

Surgical Equipment Market by Product (Sutures & Staplers, Handheld Surgical Instruments, Electrosurgical Devices, Others), Category (Reusable Surgical Equipment and Disposable Surgical Equipment), and Application (Neurosurgery, Plastic & Reconstructive Surgeries, Wound Closure, Urology, Obstetrics & Gynecology, Thoracic Surgery, Microvascular, Cardiovascular, Orthopedic Surgery, Laparoscopy, Ophthalmic Application, Veterinary Application, Dental Application, and Others): Global Opportunity Analysis and Industry Forecast, 2020-2030

Gene Therapy Market by Vector Type (Viral Vector, Non Viral Vector), by Therapy (In Vivo Therapy, Ex Vivo Therapy), by Gene Type (Antigen, Cytokine, Tumor Suppressor, Suicide, Deficiency, Growth factors, Receptors, Others), by Application (Oncological Disorders, Rare Diseases, Neurological Disorders, Other Diseases): Global Opportunity Analysis and Industry Forecast, 2020-2030

Tattoo Removal Market by Procedure (Laser Procedure, Surgical Procedure, Creams, and Other Procedures) and End User (Hospitals, Clinics, and Others): Global Opportunity Analysis and Industry Forecast, 2020-2030


About Us

Allied Market Research (AMR) is a full-service market research and business-consulting wing of Allied Analytics LLP based in Portland, Oregon. Allied Market Research provides global enterprises as well as medium and small businesses with unmatched quality of "Market Research Reports" and "Business Intelligence Solutions." AMR has a targeted view to provide business insights and consulting to assist its clients to make strategic business decisions and achieve sustainable growth in their respective market domain.

We are in professional corporate relations with various companies and this helps us in digging out market data that helps us generate accurate research data tables and confirms utmost accuracy in our market forecasting. Allied Market Research CEO Pawan Kumar is instrumental in inspiring and encouraging everyone associated with the company to maintain high quality of data and help clients in every way possible to achieve success. Each and every data presented in the reports published by us is extracted through primary interviews with top officials from leading companies of domain concerned. Our secondary data procurement methodology includes deep online and offline research and discussion with knowledgeable professionals and analysts in the industry.

 

Contact Data